Learn about FDA’s latest in biosimilar science and research.
Similar Posts
Generic Drug Research Collaboration Opportunities
The Office of Generic Drugs implements the GDUFA Regulatory Science Research Program by collaborating through grants or contracts.Applicator Recall: Integra LifeSciences Removes Extended Tip Applicator Due to Potential Sterility and Endotoxin Concerns
Extended Tip Applicator recall due to potential non-sterile product and high endotoxin levels. May cause inflammation or infection if used.A.S.K. Foods, LLC Issues Allergy Alert on Undeclared Soy in Publix Rice & Pigeon Peas
A.S.K. Foods, LLC of Palmyra, PA is recalling select 32 oz. containers of Publix Rice & Pigeon Peas because it contains undeclared soy. People who have an allergy or severe sensitivity to soy run the risk of serious or life-threatening allergic reaction if they consume this product.Public Meeting on the Reauthorization of the Prescription Drug User Fee Act (PDUFA) – 07/14/2025
On July 14, 2025, the Food and Drug Administration (FDA or Agency) held a public meeting to discuss proposed recommendations for the reauthorization of the Prescription Drug User Fee Act (PDUFA) for fiscal years (FYs) 2028 through 2032.Oasis Medical, Inc. – 707198 – 07/15/2025
CGMP/Finished Pharmaceuticals/AdulteratedE2D(R1) Post-Approval Safety Data: Definitions and Standards for Management and Reporting of Individual Case Safety Reports
E2D(R1) Post-Approval Safety Data: Definitions and Standards for Management and Reporting of Individual Case Safety Reports